Since type I IFN is known to inhibit HSC proliferation [39], it is plausible to speculate that activation of TLR3 may also directly block HSC proliferation via production of IFN-β, thereby contributing to suppression of liver fibrosis. This evidence concerns the gene TLR3 and Hepatic fibrosis.